NIH consensus panel confirms effectiveness of total knee replacement

Bethesda, Maryland -- A panel charged with reviewing all of the available evidence on total knee replacement (TKR) today found that for persons suffering from intractable and persistent knee pain and disability, TKR surgery is a safe and cost-effective therapy that restores mobility and alleviates discomfort. Over 20 years of follow-up data indicate that the procedure is successful in the vast majority of patients.

The panel reported that there is clear evidence of racial, ethnic, and gender disparities in the provision of total knee replacements, as there is for many other health care interventions, but the reasons for this are unclear. Physicians' beliefs about their patients, limited familiarity with these procedures in minority communities, and patient mistrust of the health care system may all have a role. The consensus panel is calling for more research to determine the causes of these disparities.

"TKR is not for everyone -- it's major elective surgery that carries a variety of important risks, but it often offers dramatic relief after other therapies fail," said the panel chair, orthopaedic surgeon Dr. E. Anthony Rankin of Providence Hospital in Washington, D.C. The panel emphasized that for patients considering TKR, important factors to consider include surgeon and hospital volume of TKRs performed, as these are associated with lower complication rates. Dr. Rankin explained, "Basically, the more they do, the better they do it."

Loosening of the implant is the main cause of failed total knee prostheses that necessitate revision procedures, and that proper alignment of the prosthesis is critical to minimizing long-term wear and loosening of the implant. The panel noted that computer navigation may eventually reduce the risk of substantial malalignment, but the technology is as yet unproven and its cost may be prohibitive for many hospitals.

These findings are part of the panel's consensus statement, presented at the close of t

Contact: Kelli Marciel
NIH/Office of the Director

Page: 1 2

Related biology news :

1. Study shows how consensus is attained in a noisy world
2. Anti-interferon beta antibodies in MS care: A consensus
3. NIH consensus development conference will address osteoporosis prevention, diagnosis and therapy
4. Multiple Chemical Sensitivity: A 1999 consensus
5. AAAS expert panel calls for voter-system research and reform
6. Ecologist calls for creation of an international panel to assess human behavior
7. Hydrogen Initiative report from American Physical Society panel released
8. Parenting ethics panel explores thorny issues posed by technology
9. InterAcademy panel holds general assembly in Mexico
10. NY panel to discuss bioterrorism and medical issues
11. NIH panel outlines strategies for managing tumors of the adrenal glands

Post Your Comments:

(Date:7/4/2020)... ... 03, 2020 , ... Aesthetics Biomedical (ABM), a leading aesthetics ... not only the products and treatments developed, but also the dedicated team behind ... the brands built by ABM have received several honors already for 2020, each ...
(Date:7/2/2020)... ... July 02, 2020 , ... ... announced a publication detailing the use of its revolutionary NEXTGENPCR endpoint thermocycler ... (RT-PCR) in 16 minutes. The article, titled "Ultra-fast one-step RT-PCR protocol for ...
(Date:7/1/2020)... VENICE, Calif. (PRWEB) , ... July 01, 2020 ... ... focused on building awareness and solutions for glioblastoma—the most common and aggressive adult ... and Lisa Haile, JD, PhD. Senior Fellows are charged with supporting the organization’s ...
Breaking Biology News(10 mins):
(Date:6/11/2020)... ... 2020 , ... PathSensors Inc., a Baltimore biotechnology company, announced ... program funded by the National Institute of Food and Agriculture (NIFA) entitled “Food ... goal was to engineer and develop a field-deployable instrument for portable pathogen and ...
(Date:6/3/2020)... ... June 03, 2020 , ... Thought ... of biofeedback. In the next installment, Dr. Inna Khazan will discuss the benefits ... to bring their attention to the feelings, thoughts, and emotions they are having ...
(Date:5/30/2020)... ... 2020 , ... The Conference Forum is pleased to announce ... the unique role of the Chief Medical Officer in the biotech industry. The ... practices and career development of CMOs and Heads of R&D from different therapeutic ...
(Date:5/26/2020)... ... May 26, 2020 , ... Brilliant , the ... brand of smart garage door openers, announce a new integration to bring more convenience, ... garage door openers powered by Aladdin Connect® can now be controlled from Brilliant’s in-wall ...
Breaking Biology Technology:
Cached News: